Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Infergen and Ribavirin in Chronic HCV Partial Responders
NCT00456248Phase 4Terminated
- Sponsor
- Kadmon
- Start
- Feb 2007
- Primary completion
- Oct 2007
- Modality
- PEGylated Peptides, Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 4 trial of Peginterferon alfacon-1 in hepatitis C virus infection, sponsored by Kadmon. Started Feb 2007; status: terminated.
02
Drugs
Peginterferon alfacon-1
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on NCT00456248.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00456248.